Data / Form D filings / XDemics Corp
XDemics Corp: Form D filings
XDemics Corp, a biotechnology company in San Rafael, CA, filed 5 Form D notices with the SEC between 2024 and 2026. The latest, on February 6, 2026, reports $7.4 million sold of a $7.4 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1281 Andersen Drive Suite K, San Rafael, CA, 94901
- Phone
- (415) 637-6691
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2026725
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | New notice | $7,399,999 | $7,399,999 | 1 | Oct 21, 2025 | sec.gov | |
| Dec 5, 2024 | New notice | $7,639,835 | $5,543,624 | $2,096,211 | 3 | Nov 21, 2024 | sec.gov |
| Sep 13, 2024 | Amendment | $1,850,000 | $1,850,000 | 1 | May 30, 2024 | sec.gov | |
| Jul 23, 2024 | Amendment | $1,850,000 | $1,850,000 | 1 | May 30, 2024 | sec.gov | |
| Jun 12, 2024 | New notice | $1,850,000 | $1,850,000 | 1 | May 30, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Thanos | Executive Officer, Director | |
| Colin Cook | Director | |
| Nicole Bergman | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Feb 2, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what XDemics Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.